Ascensia, Senseonics launch ad campaign

PARSIPPANY, N.J., and GERMANTOWN, Md. – Ascensia Diabetes Care and Senseonics Holdings have launched a new U.S. advertising and marketing campaign for the Eversense E3 CGM System. The “CGM for Real Life” campaign seeks to drive awareness of the Eversense E3, a six-month, implantable sensor, as well as the everyday challenges people with diabetes face. “This campaign is designed to challenge the status quo in continuous glucose monitoring, which for too long has meant self-insertion and sensors that can either disrupt activities or fall off,” said Rudy Thoms, vice president, CGM Commercial U.S., Ascensia Diabetes Care. “We know that Eversense has the potential to be game-changing for people with diabetes, and so the opportunity to bring it to the attention of more people than ever before is really exciting.” The campaign will run on TV in five states, in addition to social and digital platforms.